• to lower the potential risk of serious cardiovascular (coronary heart and blood vessel) challenges in Older people with form 2 diabetes and cardiovascular diseaseNovo Nordisk is associated with governing administration funded collaborative investigation initiatives with other industrial and governmental partners. One particular instance in the